AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 22 min read$AXON

Williams Jeri sold $102K of AXON

Williams Jeri sold 223 shares of AXON ENTERPRISE, INC. (AXON) at $455.45 ($0.10M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Williams Jeri
Published Jun 2, 2026, 9:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider activity, but the pre-arranged nature generally limits interpretability for near-term trading decisions.

02

Market read

Useful for tracking insider behavior, but not a standalone fundamental catalyst for AXON.

03

What to watch

The filing does not reveal intent beyond the plan; consider the director’s broader trading history and whether other insiders filed around the same time.

Relevance 4/10Novelty 2/10Timing: Filed after-hours/late day (2026-06-02) for a sale executed 2026-06-01.

Background

This is an SEC Form 4 insider transaction disclosure for AXON, reporting an open-market sale by a director under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Director Williams Jeri filed an open-market sale of 223 AXON shares under a pre-arranged 10b5-1 plan on 2026-06-01.

Expected impact

Low likelihood of a sustained price move from this filing alone; any impact is likely limited to short-term sentiment.

Evidence & confidence

The transaction is an open-market sale and explicitly tied to a pre-arranged 10b5-1 plan, which reduces informational content versus unscheduled sales.

Market effects

Sector

Minimal—single-company insider transaction without accompanying operational or financial catalyst.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even with 10b5-1, repeated or sizable insider sales can coincide with periods of valuation risk or personal liquidity needs—monitor for clustering of similar filings.

Key entities

  • public_company
    AXON ENTERPRISE, INC.

    Issuer of the reported insider transaction (director sale) disclosed via SEC Form 4.

  • insider
    Williams Jeri

    Director who sold 223 shares of AXON on 2026-06-01 under a 10b5-1 plan.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AXON insider trading history →

Related articles

SEP 18
$AXONHighAI 9/10

Axon’s (AXON) Dilution Fears Look Overstated

Axon Enterprise (AXON) stock fell after announcing a $1B convertible-note offering, but analysts argue dilution fears are overstated. The notes carry 0% interest, convert at $652.06, and are hedged to $1,049.94. Q2 revenue rose 35% to $904M, marking 10 straight quarters of over 30% growth. Management raised full-year revenue growth outlook to 32-34%. AXON has a Strong Buy consensus rating, with an average price target of $719.55.

tipranks.com2 min
SEP 18
$AXONHighAI 8/10

Why Did Axon Stock Fall Ten Percent On A Convertible That Pays No Interest?

Axon Enterprise (AXON) shares dropped 9.8% after announcing a $1.0 billion convertible note offering with a 0% coupon. The market interpreted this as a sign of cash flow challenges despite strong revenue growth (34.6% YoY). The company cited inventory investments and rising component costs. AXON's stock is now 43% below its 52-week high, trading at 11x trailing revenue with shrinking margins.

yahoo.com2 min
SEP 18
$AXONHighAI 9/10

Axon Q2FY26 Results: Revenue rises 35% to $904 million, guidance raised

Axon Enterprise reported Q2FY26 revenue of $904M, up 35% YoY, and raised full-year guidance to 32-34% growth. Software & services revenue rose 36% to $398M, while connected devices revenue grew 35% to $507M. Platform solutions revenue surged 123% to $150M. The company plans a $1B convertible note offering due 2031, with net proceeds for general corporate purposes and capped call transactions. Shares were up 0.50% in premarket trading.

scanx.trade3 min
SEP 18
$AXONHighAI 8/10

Full Transcript: Axon Enterprise Q2 2026 Earnings Call - (AXON)

Axon Enterprise (AXON) reported a record Q2 2026 with 39% growth, driven by demand for Dedrone, Taser 10, and Axon Body 4. The company raised its full-year revenue guidance to 32-34% growth, citing strong bookings and market expansion. Management highlighted investments in AI and public safety technologies, emphasizing trust and data privacy.

benzinga.com2 min
SEP 18
$AXONMedAI 8/10

Axon Rebounded 6% Wednesday. Here’s What Could Drive the Stock Through 2026

Axon Enterprise's stock rebounded 6% to $468 on Wednesday after a 10% drop following a $1 billion convertible notes offering. The company expects 32-34% revenue growth in 2026, with strong Q4 growth anticipated. Analysts maintain bullish targets, citing Axon's faster expansion compared to competitors like Motorola Solutions. The stock has an implied upside of 56% based on a valuation model target of $706.

tikr.com2 min